Aosha Puqin Pian (奥沙普秦片)奥沙普秦片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 葵花药业集团佳木斯鹿灵制药有限公司Chinese legal name: 葵花药业集团佳木斯鹿灵制药有限公司
主要成分Active Ingredients
- 奥沙普秦Aosha Puqin
药物知识说明
奥沙普秦是一种在国家药监局注册认定的药品。该药品含有奥沙普秦-0a45757f等成分。
该药品关联的活性成分包括：奥沙普秦Aosha Puqin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：葵花药业集团佳木斯鹿灵制药有限公司Chinese legal name: 葵花药业集团佳木斯鹿灵制药有限公司。
您可以探索含有相同成分的其他药品：奥沙普秦-0a45757f成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 奥沙普秦片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 奥沙普秦Aosha Puqin.
Manufacturers recorded for this product: 葵花药业集团佳木斯鹿灵制药有限公司Chinese legal name: 葵花药业集团佳木斯鹿灵制药有限公司.
Explore other medicines containing the same ingredient: 奥沙普秦 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 奥沙普秦片Recorded Chinese name: 奥沙普秦片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.2g×12片/盒。Recorded Chinese description: 0.2g×12片/盒。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 葵花药业集团佳木斯鹿灵制药有限公司Chinese legal name: 葵花药业集团佳木斯鹿灵制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10950306
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10950306
Manufacturer
Chinese legal name: 葵花药业集团佳木斯鹿灵制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10950306
生产企业
葵花药业集团佳木斯鹿灵制药有限公司(国产)
适应症
本品适用于风湿性关节炎，类风湿性关节炎，骨关节炎，强直性脊椎炎，肩关节周围炎，颈肩腕症候群，痛风及外伤和手术后消炎，镇痛。
用法用量
口服，一次0.2～0.4g(1～2片)，一日一次，连续服药1周以上或遵医嘱，饭后服用，最大剂量一日0.6g(3片)。
不良反应
主要为消化道症状：包括胃痛、胃不适、食欲不振、恶心、腹泻、便秘、口渴和口炎，发生率约3%～5%，大多不需停药或给予对症药物即可耐受。少见的为头晕、头痛、困倦、耳鸣和抽搐，及一过性肝功能异常。
禁忌
消化性溃疡，严重肝肾疾病患者，对其他非甾体抗炎药过敏患者，血液病患者，粒细胞减少症、血小板减少症。
注意事项
（1）有消化道溃疡、出血病史患者慎用。（2）长期服用者有肝肾功能、血象异常则宜停药观察。（3）当与口服抗凝剂并用时应慎重。
贮藏
遮光，密封保存。
规格
0.2g×12片/盒。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.